UnknownNCT05307042

Decline in Renal Concentration Ability in Lithium Treated Patients

Studying Arginine vasopressin resistance

Last synced from ClinicalTrials.gov May 4, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Radboud University Medical Center
Principal Investigator: T. Nijenhuis
Radboud University Medical Center
Intervention: Deamino Arginine Vasopressin (dDAVP)(diagnostic_test)
Enrollment: 51 enrolled
Eligibility: 18 years · All sexes
Timeline: 2022 – 2022

Study locations (1)

Canisius Wilhelmina Ziekenhuis, Nijmegen, Gelderland, Netherlands

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05307042 on ClinicalTrials.gov

Other trials for Arginine vasopressin resistance

Additional recruiting or active studies for the same condition.

ACTIVE NOT RECRUITINGPHASE4NCT05044611
AMIloride for the Treatment of Nephrogenic Diabetes Insipidus for Patients With Bipolar Disorder Treated With Lithium
Assistance Publique - Hôpitaux de Paris

See all trials for Arginine vasopressin resistance →

← Back to all trials